SCHEMBL29944875

SCHEMBL29944875

CCOc1ccc(N(C)S(=O)(=O)c2ccsc2C(=O)Nc2cccc(C(C)=O)c2)cc1

nearest known ligand 0.75

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 10/20 0.75
NR1H3 Q13133 7/20 0.75
NR1H2 P55055 7/20 0.75
KMT2A Q03164 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 3/20 0.53
NPC1 O15118 3/20 0.49
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
RAB9A P51151 2/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
MAPK1 P28482 1/20 0.48
RECQL P46063 1/20 0.47
MITF O75030 1/20 0.47
PAX8 Q06710 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27030433 1.00 SREBF1 (0.75) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL29944885 0.94 SREBF1 (0.74) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL27030385 0.94 SREBF1 (0.74) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL27030466 0.93 SREBF1 (0.73) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL29944865 0.93 SREBF1 (0.73) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL27245358 0.93 SREBF1 (0.85) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL27030557 0.93 SREBF1 (0.73) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL27030601 0.92 SREBF1 (0.89) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL29944846 0.92 SREBF1 (0.72) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2
SCHEMBL27245376 0.92 SREBF1 (0.72) SREBF1NR1H3NR1H2KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed